Ganguli et al. show that CDKN2A loss in Barrett’s esophagus prevents esophageal adenocarcinoma initiation by counterselecting subsequent TP53 loss and report context-dependent effects of 9p21 ...

Gross profit and EBITDA each show the earnings of a company but they calculate profit in different ways. Investors and analysts may want to look at both profit metrics to gain a better ...

Pulmonary angiography is a test that studies blood flow in your lungs. Its purpose is to find problems such as pulmonary embolisms (blood clots in your lungs), stenosis (narrowed blood vessels), or ...

A new method of scanning lungs is able to show the effects of treatment on lung function in real time and enable experts to see the functioning of transplanted lungs. This could enable medics to ...

After your final cigarette, your lungs start working to clean themselves. Some habits, like exercise and avoiding pollutants, may help support your lung health. If you’ve recently quit smoking ...

The phase 2 TROPiCS-03 study showed a 41.9% overall response rate for Trodelvy in ES-SCLC, with all responses being partial. Trodelvy targets TROP2, a cell surface antigen in over 90% of breast and ...

Therefore, the application of deep learning models to segment and quantitatively predict PD-L1 expression in digital sections of Hematoxylin and eosin (H&E) stained lung squamous cell carcinoma is of ...

Squamous cell carcinoma of the lung (LUSC) stands as the second most prevalent form of non–small cell lung cancer (NSCLC), constituting 20%-30% of patients with ...

Dec. 19, 2024 – The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC). Sold under the brand name ...